Jose-Carlos (JC) Gutierrez-Ramos, Ph.D. serves as AbbVie’s Vice President of Discovery, where he leads a global team of scientists who work to identify potential new treatments for a variety of diseases. JC has diverse leadership experience across multiple biotech start-ups and peer companies and deep expertise in translating new areas of science into successful drug discovery programs.
Prior to joining AbbVie, JC was most recently the founding CEO and President at Cogen Immune Medicine where he built and led a team to decode the human immunome. Previously, he was President and CEO of Synlogic, where he led the company from early discovery to the clinical stage and to the public markets. JC has served as group senior vice president of worldwide research and development and global head of biotherapeutics at Pfizer and GSK, respectively. In these Global positions, he oversaw multiple drug discovery teams that have resulted in two marketed drugs.
JC has a Ph.D. in immunology from the Universidad Autonoma de Madrid and trained as an immunologist in Spain, Germany and Switzerland. He started his academic career as Assistant Professor of Genetics at Harvard Medical School. He has authored more than 150 peer-reviewed publications.